cutaneous systemic sclerosis. This multicenter, randomized, double-blind study included 43 patients with systemic sclerosis of <18 months' duration. In total, 10 patients received CAT-192 10 mg/kg ...

New research has uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma – a rare and often ...

The following is a summary of “A Phase 2 randomised trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients ...

Hole, says that his lungs are so weak that he has to have chemotherapy and cancer tablets, despite not having any form of ...

She has severe fatigue, arthralgias, and tight, itchy skin on her face ... a nearby university medical department who diagnoses systemic sclerosis. She and her husband are frightened, especially ...

New research recommends that clinicians screen for foot peripheral sensory neuropathy during initial assessments for patients with systemic sclerosis.

Scleroderma symptoms may be localized, primarily affecting the skin and underlying tissues. It may also be systemic, affecting your skin as well as the blood vessels and tissues of major organ ...

CREST syndrome is a form of scleroderma, specifically limited systemic scleroderma. Its symptoms affect the skin, joints, and blood vessels and progress more slowly than other forms of systemic ...

digestive and cutaneous diseases. These relatively new agents are being used for a rapidly expanding number of systemic autoimmune diseases, including SSc—although they are not yet approved in ...

Substantial evidence exists that patients with scleroderma have immune dysfunction and autoimmunity, and several studies support the use of immunosuppressive treatment in these patients.

Systemic Scleroderma Treatment Market 2032 The systemic scleroderma treatment market is set to grow from USD 1.34 Bn in 2025 to USD 1.99 Bn ...

Adds to Extensive Preclinical and Early Clinical Evidence that Nebokitug Interferes with Key Features of Systemic SclerosisTEL AVIV, Israel, ...